Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-2 Plasma Lipoprotein Response
NCT03422666Phase 3Completed
- Sponsor
- University Health Network
- Start
- Sep 2018
- Primary completion
- Jun 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in hyperlipidemia, sponsored by University Health Network. Started Sep 2018; status: completed.
02
Drugs
teduglutide
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT03422666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422666.